Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 years.

Abstract Objective The present study aimed to evaluate oncologic outcomes, patient-reported outcomes (PROs), and frailty in older adult patients aged ≥75 years who underwent robot-assisted radical prostatectomy (RARP). Materials and methods This retrospective study reviewed the medical records of 752 patients who underwent RARP from July 2011 to May 2020. The PROs were evaluated by Expanded Prostate Cancer Index Composite questionnaire at baseline and 1 year after RARP. Patients were divided into 3 groups according to age at RARP: Results Median follow up was 47 months. Of the 752 patients, 469, 216, and 74 were classified into the Conclusion The oncologic outcomes and PROs in select patients with prostate cancer aged ≥75 years were feasible and acceptable with RARP.